2013/9/25 12:00
Condition: Breast Neoplasms
Interventions: Drug: Vintafolide 2.5 mg; Drug: Paclitaxel 80 mg/m^2; Drug: Etarfolatide; Drug: Folic acid; Drug: Premedication for Paclitaxel
Sponsors: Merck; Merck
Not yet recruiting - verified September 2013
2013/7/23 12:00
Condition: Healthy
Interventions: Drug: lesinurad 400 mg; Drug: ranitidine 150 mg; Drug: lesinurad 400 mg + ranitidine 150 mg
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Not yet recruiting - verified July 2013
2013/6/19 12:00
Condition: VA Drug Interactions [VA Drug Interaction]
Intervention: Drug: omeprazole
Sponsors: University of Sao Paulo General Hospital; University of Sao Paulo General Hospital; InCor Heart Institute
Active, not recruiting - verified October 2011
2012/11/24 12:00
Condition: Dyspepsia
Interventions: Drug: Pantoprazole; Drug: Ranitidine
Sponsors: Akdeniz University; Akdeniz University
Recruiting - verified November 2012
2012/11/17 12:00
Condition: Healthy
Intervention: Drug: Taste Test
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified November 2012
2012/11/6 12:00
Conditions: Adenocarcinoma of the Oesophagus; Adenocarcinoma of the Oesophago-gastric Junction; Oesophageal Tumours; Junctional Tumours; Oesophageal Cancer
Interventions: Drug: Epirubicin; Drug: Cisplatin; Drug: 5 Flourouracil/ Capecitabine; Radiation: (41.4 Gy/23 fractions); Drug: Paclitaxel; Drug: Carboplatin
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Not yet recruiting - verified November 2012
2012/10/15 12:00
Condition: Gastro Oesophageal Cancer
Interventions: Drug: Epirubicin; Drug: Oxaliplatin; Drug: Capecitabine; Drug: Docetaxel
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Active, not recruiting - verified October 2012
2012/2/15 12:00
Condition: Reflux Oesophagitis
Interventions: Drug: YF476; Drug: Ranitidine
Sponsors: Trio Medicines Ltd.; Ferring Pharmaceuticals
Completed - verified February 2012
2012/2/10 12:00
Conditions: Pharmacokinetic; Cmax; Tmax; Plasma AUC; Plasma [AUC(0-t)]; Plasma [AUC(0-672)]; (t1/2,λz)
Interventions: Drug: vandetanib; Drug: omeprazole; Drug: ranitidine
Sponsor: AstraZeneca
Not yet recruiting - verified February 2012
2011/8/5 12:00
Condition: Neoplasms
Intervention: Drug: BAY80-6946
Sponsor: Bayer
Not yet recruiting - verified August 2011
2011/7/11 12:00
Condition: Healthy Volunteer
Interventions: Drug: danoprevir; Drug: ritonavir; Drug: omeprazole; Drug: ranitidine
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified July 2011
2011/1/10 12:00
Condition: Healthy Adult
Intervention: Drug: Metformin
Sponsor: Yonsei University
Recruiting - verified January 2011
2010/12/15 12:00
Conditions: Parapneumonic Pleural Effussion; Empyema
Interventions: Drug: Dexamethasone; Drug: Placebo
Sponsors: Hospital Infanta Sofia; Pediatrics Spanish Association (Madrid and Castilla-La Mancha Pediatric Association); Spanish Ministry of Health.
Recruiting - verified December 2010
2010/11/24 12:00
Conditions: Ovarian Cancer; Malignant Tumor of Peritoneum
Interventions: Drug: carboplatin; Drug: carboplatin
Sponsors: Memorial Sloan-Kettering Cancer Center; National Institutes of Health (NIH)
Recruiting - verified March 2011
2010/9/24 12:00
Condition: Poisoning
Interventions: Drug: Chlorphenamine and Ranitidine; Drug: Paracetamol; Drug: Paracetamol
Sponsors: University of Edinburgh; NHS Lothian
Not yet recruiting - verified September 2010
2010/5/26 12:00
Condition: Healthy
Intervention: Drug: Ranitidine
Sponsor: Dr. Reddy's Laboratories Limited
Completed - verified June 2010
2010/3/1 12:00
Conditions: Ovarian Cancer; Malignant Tumor of Peritoneum; Fallopian Tube Cancer; Intestinal Obstruction
Interventions: Drug: Cisplatin; Drug: Paclitaxel
Sponsor: University Health Network, Toronto
Recruiting - verified February 2011
2010/2/22 12:00
Condition: Hemangioma
Interventions: Drug: Prednisolone (Corticosteroid); Drug: Propanolol; Drug: Placebo
Sponsor: Seattle Children's Hospital
Recruiting - verified August 2010
2010/1/4 12:00
Condition: Multiple Myeloma
Interventions: Drug: Bendamustine; Drug: Lenalidomide; Drug: Dexamethasone; Drug: Aspirin; Drug: Prophylaxis; Drug: Antibiotic; Other: Biweekly Follow Up; Other: Cyclical Follow Up; Other: Restaging; Other: Post-Treatment Follow Up
Sponsors: University of Pittsburgh; Cephalon
Active, not recruiting - verified March 2011
2009/12/17 12:00
Conditions: Vomiting; Cisplatin; Antineoplastic Combined Chemotherapy Protocols
Interventions: Drug: Placebo; Drug: Gabapentin
Sponsor: Faculdade de Medicina do ABC
Recruiting - verified January 2009